The study found that CML promoted vascular calcification through different pathways in diabetes, including p38 MAPK pathway and the nuclear factor of activated T-cells 1 (NFATc1) (90, 91). This evidence concerns the gene NFATC1 and chronic myelogenous leukemia, BCR-ABL1 positive.